| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2025 | MEDP Medpace Holdings, Inc. | Geiger Jesse J | President | Sell | 41,801 | $453.11 | $18,940,451.11 | -53.4% | |
| Jul 24, 2025 | MEDP Medpace Holdings, Inc. | Brady Kevin M. | CFO &Treasurer | Sell | 12,000 | $454.23 | $5,450,760.00 | -66.7% | |
| Jul 24, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes | Chief Financial Officer | Sell | 2,170 | $139.94 | $303,668.67 | -0.8% | |
| Jul 23, 2025 | IQV Iqvia Holdings Inc. | Sherbet Eric | See Remarks | Sell | 5,800 | $190.05 | $1,102,290.00 | -17.6% | |
| Jul 23, 2025 | IQV Iqvia Holdings Inc. | Cherofsky Keriann | See Remarks | Sell | 549 | $191.53 | $105,149.97 | -15.9% | |
| Jul 23, 2025 | TWST Twist Bioscience Corp | Finn Patrick John | President And COO | Sell | 2,232 | $35.74 | $79,773.91 | -0.9% | |
| Jul 21, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 1,622 | $139.29 | $225,928.38 | -0.9% | |
| Jul 21, 2025 | NTRA Natera, Inc. | Sheena Jonathan | - | Sell | 93 | $139.29 | $12,953.97 | - | |
| Jul 21, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes | Chief Financial Officer | Sell | 602 | $139.29 | $83,852.58 | -0.8% | |
| Jul 21, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel | Sec. And Chief Legal Officer | Sell | 464 | $139.29 | $64,630.56 | -0.2% | |
| Jul 21, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 291 | $139.29 | $40,533.39 | -0.2% | |
| Jul 21, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 339 | $139.29 | $47,219.31 | -0.2% | |
| Jul 17, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $48.20 | $5,591.20 | -1.6% | |
| Jul 17, 2025 | GH Guardant Health, Inc. | Potter Myrtle S | Director | Sell | 26 | $48.20 | $1,253.20 | -0.1% | |
| Jul 16, 2025 | NTRA Natera, Inc. | Sheena Jonathan | Director, Co-founder | Sell | 3,070 | $149.96 | $460,387.95 | -1.2% | |
| Jul 15, 2025 | GRAL Grail, Inc. | Freidin Aaron | Chief Financial Officer | Sell | 8,000 | $38.93 | $311,440.00 | -2.7% | |
| Jul 9, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 5,278 | $93.00 | $490,854.00 | -60.9% | |
| Jul 9, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 3,220 | $93.00 | $299,460.00 | -65.2% | |
| Jul 9, 2025 | TWST Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Sell | 2,449 | $38.15 | $93,419.55 | -2.3% | |
| Jul 8, 2025 | PRPO Precipio, Inc. | Sabet Ahmed Zaki | Chief Operating Officer | Buy | 31 | $16.30 | $505.30 | +4.7% | |
| Jul 7, 2025 | CDNA Caredx, Inc. | Maag Peter | Director | Sell | 10,000 | $18.58 | $185,831.00 | -3.1% | |
| Jul 2, 2025 | NTRA Natera, Inc. | Sheena Jonathan | Director, Co-founder | Sell | 200 | $159.23 | $31,845.00 | -0.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.